Most managers of pharmaceutical R&D define “translational science” as the translation of science to clinical practice by using novel means of analysis, allowing one to make inferences about the performance of a drug candidate much earlier than traditionally organized research would allow. more
Certara Companies, Pharsight and Tripos
Mark Hovde is Senior Vice President of Corporate Marketing and Business Development for Certara. Certara focuses on reducing the barriers between the phases of research to speed discoveries in chemistry and enables pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Certara owns Tripos and Pharsight. Tripos provides software for molecular discovery. Pharsight provides PK/PD software and scientific services to improve productivity and decision-making in clinical drug development.